The 2019 community meeting is hosted by the Clinical Bioinformatics Area, FPS, Hospital Virgen del Rocío.

Key dates

Abstract submission deadline: 1st July 2019
Decision on abstract selection: 1st August 2019
Registration deadline: 1st September 2019
DMCM2019: 2nd - 4th October 2019

Invited speakers

Jessica Dale Jessica Dale Tenenbaum, PhD, Duke University, USA

Dr. Tenenbaum is an Assistant Professor in the Department of Biostatistics & Bioinformatics at Duke University. Her research focuses on mining electronic health record data for stratification of mental health disorders to enable biomarker discovery. After earning her bachelor’s degree in biology from Harvard, Jessica Dale Tenenbaum worked as a program manager at Microsoft Corporation in Redmond, WA for six years before pursuing a PhD in biomedical informatics at Stanford University. More information: Tenenbaum Lab.

Julio Saez-Rodriguez Julio Saez-Rodriguez, PhD, RWTH-Aachen University, Germany

Julio Saez-Rodriguez is Professor of Medical Bioinformatics and Data Analysis at the Faculty of Medicine of Heidelberg University. Julio is a member of the Disease Maps team and participates in the development of the Multiple Sclerosis Map. Julio's research interests are in computational methods and tools for studying information transfer within signalling networks, and applications to disease-related questions, with a focus on cancer and fibrosis. More information can be found at http://saezlab.org.

Jonathan Karr Jonathan Karr, PhD, Icahn School of Medicine at Mount Sinai, USA

Jonathan Karr is a Fellow at the Icahn School of Medicine at Mount Sinai in New York. The goal of Jonathan's research group is to develop mechanistic whole-cell computational models that predict the behavior of individual cells by representing all of the biochemical activity in cells. Jonathan earned his PhD in Biophysics and his MS in Medicine from Stanford University and his SB in Physics and SB in Brain & Cognitive Sciences from MIT. See his research group's website for more information: https://www.karrlab.org.

Sampsa Hautaniemi Sampsa Hautaniemi, PhD, University of Helsinki, Finland

Sampsa Hautaniemi is a Professor of Systems Biology and the Director of Systems Oncology research program at the Faculty of Medicine of the University of Helsinki. His research focuses on developing and applying machine learning methods to understanding and overcoming drug resistance in cancers. More information can be found at the Hautaniemi lab.


Wednesday 2nd October

09:30 - 13:30 On-site registration
10:00 Disease Maps Coordinators meeting

11:00 Coffee Break

Session 1: Using existing data to create disease maps

11:30 Opening Key Lecture: Schizophrenia Map: Data to knowledge to data
Jessica Dale Tenenbaum, Duke University, Durham, North Carolina, USA
12:30 Selected short talks
The talks will be selected from the submitted abstracts.
13:30 Lunch and Poster viewing

Session 2: Computational models

14:30 Key Lecture: Toward whole-cell computational models for precision medicine
Jonathan Karr, Icahn School of Medicine at Mount Sinai, New York, USA
15:30 Selected short talks

Thursday 3rd October

Session 3: Multi-view data integration

9:00 Key Lecture: Logic modelling to integrate disease maps and various omics data
Julio Saez-Rodriguez, RWTH-Aachen University Hospital, Aachen, Germany
10:00 Highlighted talk

10:30 Coffee break and poster viewing

11:00 Selected short talks
The talks will be selected from the submitted abstracts.
12:30 Poster session

13:30 Lunch and poster viewing

14:30 Introducing discussion topics
15:00 - 17:00 Breakout discussions
17:00 - 18:00 Presenting results of the discussions

Session 4: Discussions

Afternoon breakout discussion sessions are planned following the example of the 2nd Disease Maps Community Meeting in Luxembourg. We invite proposals: a title and a brief description of the topic (1 page maximum). 4-6 topics will be selected, introduced 2nd October and discussed 3rd and 4th October with summaries presented at the end to all the participants. The outcome of the Luxembourg meeting discussions was published receintly in Briefings in Bioinformatics: doi: 10.1093/bib/bby024.

17:00 - 18:00 Concluding remarks

20:30 Gala Dinner

Friday 4th October

Session 5: Clinical application of disease maps

10:00 Key Lecture: Computational approaches to tackle chemoresistance in high-grade serous ovarian cancer
Sampsa Hautaniemi, Faculty of Medicine, University of Helsinki, Finland
11:00 Highlighted talk

11:30 Coffee break and poster viewing

12:30 Selected short talks
The talks will be selected from the submitted abstracts.
13:30 Meeting closure

Abstract submission

Please submit an abstract (up to 400 words) via the submission link for an oral presentation and/or a poster.

Abstract submission deadline: 1st July 2019.


The registration is free but mandatory. Please fill in the registration form.

Registration deadline: 1st September 2019.


C.D.C.A.. Building, Hospital Universitario Virgen del Rocío
Avenida Manuel Siurot s/n, 41013 Seville, Spain


Recommended hotels:

AC Hotel Ciudad de Sevilla, a Marriott Lifestyle Hotel
AV Manuel Siurot 25, 41013 Seville, Spain
Tel. +34 954 230 505

Silken Al-Andalus Palace
Avenida de la Palmera s/n, esq. C/ Paraná, 41012 Seville, Spain
Tel. +34 954 230 600

EXE Sevilla Palmera
Cardenal Ilundain, 28, 41013 Seville, Spain
Tel. +34 932 087 108

Melia Sevilla
Dr. Pedro de Castro, 1, 41004 Seville, Spain
Tel. +34 912 764 747


Local organisers

Clinical Bioinformatics Area Group
Joaquin Dopazo
Rubén García Serrano
Maria Peña Chilet

Disease Maps Project Coordinators

Alexander Mazein
Marek Ostaszewski
Inna Kuperstein
Andrei Zinovyev
Reinhard Schneider
Emmanuel Barillot
Rudi Balling
Charles Auffray


If you have any questions, please contact Inmaculada Guillén at the technical secretariat of the CBA group and the Disease Maps Organisers.

Supported by

inb iscii

The Spanish National Bioinformatics Institute (INB) is the ISCIII Bioinformatics platform. Its Coordination Node is supported by grant PT17/0009/0001, of the Acción Estratégica en Salud 2013-2016 of the Programa Estatal de Investigación Orientada a los Retos de la Sociedad, funded by the Instituto de Salud Carlos III (ISCIII) and European Regional Development Fund (ERDF)